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Articles

Use of quantitative molecular diagnostic methods to assess
the aetiology, burden, and clinical characteristics of diarrhoea
in children in low-resource settings: a reanalysis of the
MAL-ED cohort study
James A Platts-Mills*, Jie Liu*, Elizabeth T Rogawski, Furqan Kabir, Paphavee Lertsethtakarn, Mery Siguas, Shaila S Khan, Ira Praharaj,
Arinao Murei, Rosemary Nshama, Buliga Mujaga, Alexandre Havt, Irene A Maciel, Timothy L McMurry, Darwin J Operario, Mami Taniuchi,
Jean Gratz, Suzanne E Stroup, James H Roberts, Adil Kalam, Fatima Aziz, Shahida Qureshi, M Ohedul Islam, Pimmada Sakpaisal, Sasikorn Silapong,
Pablo P Yori, Revathi Rajendiran, Blossom Benny, Monica McGrath, Benjamin J J McCormick, Jessica C Seidman, Dennis Lang, Michael Gottlieb,
Richard L Guerrant, Aldo A M Lima, Jose Paulo Leite, Amidou Samie, Pascal O Bessong, Nicola Page, Ladaporn Bodhidatta, Carl Mason,
Sanjaya Shrestha, Ireen Kiwelu, Estomih R Mduma, Najeeha T Iqbal, Zulfiqar A Bhutta, Tahmeed Ahmed, Rashidul Haque, Gagandeep Kang,
Margaret N Kosek, Eric R Houpt, and The MAL-ED Network Investigators†

Summary

Background Optimum management of childhood diarrhoea in low-resource settings has been hampered by
insufficient data on aetiology, burden, and associated clinical characteristics. We used quantitative diagnostic methods
to reassess and refine estimates of diarrhoea aetiology from the Etiology, Risk Factors, and Interactions of Enteric
Infections and Malnutrition and the Consequences for Child Health and Development (MAL-ED) cohort study.
Methods We re-analysed stool specimens from the multisite MAL-ED cohort study of children aged 0–2 years done at
eight locations (Dhaka, Bangladesh; Vellore, India; Bhaktapur, Nepal; Naushero Feroze, Pakistan; Venda, South Africa;
Haydom, Tanzania; Fortaleza, Brazil; and Loreto, Peru), which included active surveillance for diarrhoea and routine
non-diarrhoeal stool collection. We used quantitative PCR to test for 29 enteropathogens, calculated population-level
pathogen-specific attributable burdens, derived stringent quantitative cutoffs to identify aetiology for individual
episodes, and created aetiology prediction scores using clinical characteristics.
Findings We analysed 6625 diarrhoeal and 30 968 non-diarrhoeal surveillance stools from 1715 children. Overall,
64·9% of diarrhoea episodes (95% CI 62·6–71·2) could be attributed to an aetiology by quantitative PCR compared
with 32·8% (30·8–38·7) using the original study microbiology. Viral diarrhoea (36·4% of overall incidence,
95% CI 33·6–39·5) was more common than bacterial (25·0%, 23·4–28·4) and parasitic diarrhoea (3·5%, 3·0–5·2).
Ten pathogens accounted for 95·7% of attributable diarrhoea: Shigella (26·1 attributable episodes per 100 child-years,
95% CI 23·8–29·9), sapovirus (22·8, 18·9–27·5), rotavirus (20·7, 18·8–23·0), adenovirus 40/41 (19·0, 16·8–23·0),
enterotoxigenic Escherichia coli (18·8, 16·5–23·8), norovirus (15·4, 13·5–20·1), astrovirus (15·0, 12·0–19·5),
Campylobacter jejuni or C coli (12·1, 8·5–17·2), Cryptosporidium (5·8, 4·3–8·3), and typical enteropathogenic E coli
(5·4, 2·8–9·3). 86·2% of the attributable incidence for Shigella was non-dysenteric. A prediction score for shigellosis
was more accurate (sensitivity 50·4% [95% CI 46·7–54·1], specificity 84·0% [83·0–84·9]) than current guidelines,
which recommend treatment only of bloody diarrhoea to cover Shigella (sensitivity 14·5% [95% CI 12·1–17·3],
specificity 96·5% [96·0–97·0]).
Interpretation Quantitative molecular diagnostics improved estimates of pathogen-specific burdens of childhood
diarrhoea in the community setting. Viral causes predominated, including a substantial burden of sapovirus; however,
Shigella had the highest overall burden with a high incidence in the second year of life. These data could improve the
management of diarrhoea in these low-resource settings.
Funding Bill & Melinda Gates Foundation.
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.

Introduction
Although diarrhoea mortality has declined substantially
since 1990, diarrhoeal incidence and morbidity remain
a substantial problem.1–3 Studies of diarrhoea aetiology
have focused on children presenting to care, but this only
represents a minority of diarrhoea episodes.4 Improved

estimates of the aetiology and burden of diarrhoea at the
community level could help ameliorate this morbidity
by informing treatment guidelines and public health
interventions.
The application of molecular diagnostics for entero-
pathogens has provided increased sensitivity and,
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Research in context
Evidence before this study
We searched PubMed for articles published in any language since
Jan 1, 1990, using the search terms “(diarrhea OR diarrhoea) AND
(etiology OR aetiology OR cause*) AND (pediatric OR paediatric
OR infant* OR children) AND cohort AND (PCR OR molecular)”.
We identified 370 publications, of which four estimated
pathogen-specific diarrhoea burdens for more than a single
pathogen from prospective child cohorts. Of these, two used
a pan-molecular diagnostic approach: the first study was done
in the USA and the second was done at a single site and did
not incorporate pathogen quantity.
Added value of this study
This study provides a comprehensive, multisite assessment of
the aetiology of childhood diarrhoea of any severity using
quantitative PCR for a broad range of enteropathogens in the
context of home-based surveillance. This approach provided a
complete overview of the aetiology and burden of infectious

through quantification, resolution to identify causes of
diarrhoea.5,6 These studies have revealed that some
pathogens, including Shigella, enterotoxigenic Escherichia
coli, and adenovirus 40/41 have been underestimated as
causes of diarrhoea. Outside of cholera-endemic settings,
WHO guidelines7 recommend antimicrobial therapy only
for children with bloody diarrhoea as a surrogate for
shigellosis diagnosis. However, in practice antibiotics are
used much more broadly,8 and the presence of blood in
stools is a poor marker of Shigella infection.6,9,10 Moreover,
shigellosis has been associated with mortality indepen
dent of dysentery.10 Although broader antibiotic treatment
of diarrhoea might thus be beneficial, this benefit must
be weighed against increasing antibiotic resistance,
which is a growing concern and might disproportionately
affect children in these settings.11,12
We have previously reported diarrhoea aetiology
estimates in the Etiology, Risk Factors, and Interactions of
Enteric Infections and Malnutrition and the Consequences
for Child Health and Development (MAL-ED) multisite
birth cohort study,13 using qualitative diagnostics to assess
a subset of specimens.14 In this study, we retested stool
specimens from the MAL-ED study using quantitative
PCR to refine these aetiology estimates, test for a broader
range of pathogens, and identify clinical characteristics
that might help discriminate between different causes,
guide treatment algorithms, and improve antibiotic use
for children with diarrhoea in low-resource settings.

Methods

Study design and participants
The MAL-ED study design has been previously described.13
Between November, 2009, and February 2012, children
were enrolled from the community within 17 days of
birth at eight locations: Dhaka, Bangladesh; Vellore, India;
2

diarrhoea and assessed the value of clinical characteristics to
better target syndromic treatment of diarrhoea in these
settings. Our study identified several pathogens, including
Shigella, sapovirus, and adenovirus 40/41, as major aetiologies
of childhood diarrhoea that were either missed or the burden
of which was substantially underestimated by previous
microbiological approaches. These results suggest that
incorporation of clinical characteristics other than blood
(such as child age) into antibiotic treatment guidelines
might be of value.
Implications of all available evidence
Ten enteropathogens are responsible for most cases of infectious
diarrhoea in children in low-resource settings, including several
that were previously underestimated. Because of the high
burden of Shigella, and because only a minority of shigellosis is
dysenteric, guidelines for antibiotic treatment of childhood
diarrhoea that focus on dysentery should be reviewed.

Bhaktapur, Nepal; Naushero Feroze, Pakistan; Venda,
South Africa; Haydom, Tanzania; Fortaleza, Brazil; and
Loreto, Peru. Children were included if their mother was
aged 16 years or older, their family intended to remain in
the study area for at least 6 months from enrolment, they
were from a singleton pregnancy, and they had no other
siblings enrolled in the study. Children with a birthweight
or enrolment weight of less than 1500 g and children
diagnosed with congenital disease or severe neonatal
disease were excluded. All sites received ethics approval
from their respective governmental, local institutional,
and collaborating institutional ethics review boards.
Written informed consent was obtained from the parent
or guardian of every child.

Surveillance and sample collection
Fieldworkers visited children twice weekly for surveillance
of child illnesses, antibiotic use, and vaccine admini
stration. Diarrhoea was defined as maternal report of
three or more loose stools in 24 h, or one stool with visible
blood. Episodes separated by 48 h without study-defined
diarrhoea were considered distinct episodes. The duration,
number of loose stools in 24 h, presence of dehydration,
fever, and vomiting were also recorded for each episode of
diarrhoea. Dehydration was defined as irritability that was
difficult to console, increased thirst, loss of skin turgor,
sunken eyes, or lethargy.7 Diarrhoea for 7 days or more
was considered a prolonged episode, and a high frequency
was defined as more than 6 stools in any 24 h period
during an episode. A diarrhoea severity score was
calculated for every episode as previously described.14
Diarrhoeal and monthly non-diarrhoeal surveillance stool
specimens were collected. Diarrhoea was considered to be
treated by antibiotics if antibiotic use was reported on any
day of the diarrhoea episode, and inappropriate antibiotic
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use was defined post hoc on the basis of a microbiological
gold standard as either unnecessary treatment (ie,
for non-Shigella diarrhoea) or inappropriate antibiotic
selection (ie, use of an antibiotic class other than
fluoroquinolones or macrolides for Shigella diarrhoea).15–18

Stool testing
All diarrhoeal stools and non-diarrhoeal stools collected
for surveillance for months 1–12, 15, 18, 21, and
24 were analysed according to a standardised protocol, as
previously described.14,19 We used all available diarrhoeal
and monthly non-diarrhoeal stool specimens from
children who had complete follow-up to age 24 months.
We used custom-designed TaqMan Array Cards (Thermo
Fisher, Carlsbad, CA, USA) that compartmentalised
probe-based quantitative PCR assays for 29 entero
pathogens. Assays for Plesiomonas shigelloides were
included on a subset of cards. All procedures, including
assay validation, nucleic acid extraction, quantitative
PCR setup, and quality control have been described
previously (appendix).20,21 Raw stool aliquots were stored
at –80°C before extraction. Bacteriophage MS2 was used
as an external control to monitor efficiency of nucleic
acid extraction and amplification. We included one
extraction blank per batch and one no-template amplifi
cation control per ten cards to exclude laboratory
contamination. The detection of rotavirus was considered
false positive if obtained within 28 days of rotavirus
vaccine administration. Both Shigella and enteroinvasive
E coli can be detected using the ipaH target; however, on
the basis of previous findings6,22 and for simplicity, we
considered the detection of ipaH to be consistent with
Shigella infection.

Statistical analysis
For all analyses, we used the quantification cycle value as
an inverse measure of pathogen quantity, whereby
one quantification cycle unit corresponds to a doubling
in quantity. A quantification cycle of 35 was considered
the analytical limit of detection. We estimated pathogenspecific burdens of diarrhoea by calculating attributable
fractions, which incorporate both the frequency of
pathogen detection in diarrhoea and the association
between pathogen quantity and diarrhoea.23 This allowed
for differential attribution of aetiology based on the
amount of pathogen nucleic acid present. To estimate
this association, a generalised linear mixed-effects model
(GLMM) was fit for each pathogen, whereby the outcome
was diarrhoea, and predictors were the quantity of the
modelled pathogen, the quantity of each other pathogen,
child sex, test batch, child age in 3 month intervals, an
interaction between pathogen quantity and child age, a
random slope for each site, and a random intercept for
each individual. A quadratic term for the quantity of the
modelled pathogen was considered if the prevalence in
diarrhoea at any quantity was at least 5% and included
if it improved model fit on the basis of the Akaike

information criterion. Non-diarrhoeal stools were
required to be collected at least 7 days before and after
any diarrhoea episode. All pathogens with at least one
detection at any quantity in diarrhoeal stools and any
association with diarrhoea in single-pathogen analysis
(ie, the same model but without adjustment
for other pathogens) were included in the final analysis.
Attributable fractions were calculated by summing the
pathogen attributable fraction for each episode (AFe)
across each of j episodes with the following equation:
j

Σ
i=1

1
× AFei
j

where
AFei = 1 –

1
ORei

and ORe is the pathogen-specific and quantity-specific
odds ratio from the GLMM for each episode. Attributable
incidence rates were calculated as the product of the
number of episodes identified by surveillance and the
attributable fractions divided by the number of child
years at risk and expressed as rates per 100 childyears. 95% CIs were estimated by bootstrapping with
1000 iterations.
To estimate the association between pathogenattributable diarrhoea and clinical characteristics, a
single GLMM was fit for each characteristic and
included the AFe for each pathogen, child age, a
quadratic term for age, and nested random effects for
site and individual. Coefficients were scaled to the AFe
range for each pathogen. An AFe for non-infectious
diarrhoea was defined as one minus the sum of all
pathogen-specific AFes with a lower bound of zero. To
assess model-based prediction of pathogen-attributable
episodes, we first identified aetiologic detections for
each episode, using a stringent quantitative cutoff
(AFe ≥0·5; appendix). If more than one aetiology was
identified, the pathogen with the highest AFe was
considered the primary aetiology, and all others were
considered secondary aetiologies. We then derived a
prediction score from a GLMM, with an outcome of an
aetiologic episode, and predictors of blood in stool,
fever, prolonged duration, dehydration, vomiting, high
stool frequency, and child age in 3 month intervals and
nested random effects for site and individual. The fixed
effects coefficients were scaled, rounded, and summed.
We fit a receiver operating characteristic curve, and the
lowest score that achieved at least 80% specificity was
selected as the cutoff. For each prediction score, a
diarrhoea episode was considered positive if it had a
score greater than or equal to the cutoff. The Youden
Index24 was calculated as sensitivity + specificity – 1, and
95% CIs were calculated using the binomial distribution.
All analyses were done in R version 3.4.3.
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Children
enrolled

Children with Diarrhoea
follow-up to episodes
reported
24 months

Diarrhoea
Diarrhoea stools Diarrhoea
stools available stools with
collected from
valid results*
unique episodes for testing

Surveillance Surveillance
stools available
stools
for testing
collected

Surveillance
stools with
valid results*

Surveillance stools
included in the
aetiology analysis†

Dhaka, Bangladesh

265

210

1520

1438 (94·6%)

1392 (96·8%)

1374 (98·7%)

4528

4353 (96·1%)

4267 (98·0%)

3787

Vellore, India

251

227

960

722 (75·2%)

675 (93·5%)

623 (92·3%)

5058

4924 (97·4%)

4689 (95·2%)

2767

Bhaktapur, Nepal

240

227

1060

955 (90·1%)

911 (95·4%)

899 (98·7%)

5160

5065 (98·2%)

5011 (98·9%)

4457

Naushero Feroze,
Pakistan

277

246

3110

2123 (68·3%)

1871 (88·1%)

1789 (95·6%)

4871

4676 (96·0%)

4499 (96·2%)

4518
3458

Venda, South Africa

314

237

295

179 (60·7%)

147 (82·1%)

113 (76·9%)

5399

5160 (95·6%)

4428 (85·8%)

Haydom, Tanzania

262

209

537

178 (33·1%)

164 (92·1%)

155 (94·5%)

4657

4345 (93·3%)

4033 (92·8%)

3833

Fortaleza, Brazil

233

165

168

117 (69·6%)

100 (85·5%)

88 (88·0%)

3242

2994 (92·4%)

2795 (93·4%)

4291

Loreto, Peru
Total

303

194

1742

1642 (94·3%)

1617 (98·5%)

1584 (98·0%)

4301

4236 (98·5%)

4059 (95·8%)

3857

2145

1715

9392

7354 (78·3%)

6877 (93·5%)

6625 (96·3%)

37 216

35 753 (96·1%)

33 781 (94·5%)

30 968

Data are n or n (%). *Valid results required for all 27 enteropathogens included in the aetiology analysis (Plesiomonas was included on a subset of cards [5015 of 6877 tested diarrhoeal stools and 32 276 of
35 753 tested surveillance stools]). †For the aetiology analysis, only surveillance stools that were collected at least 7 days both before and after any reported episode of diarrhoea were included.

Table 1: Diarrhoea surveillance, sample collection, and stool testing by quantitative PCR in the MAL-ED cohort

Role of the funding source

40/41 (17·2, 14·3–22·2) had the highest attributable
incidence (figure 1). Across both years, diarrhoea
incidence was 273·8 episodes per 100 child-years, and
95·7% of attributable diarrhoea was attributed to ten
pathogens: Shigella (26·1 attributable episodes per
100 child-years, 95% CI 23·8–29·9), sapovirus
(22·8, 18·9–27·5), rotavirus (20·7, 18·8–23·0), adenovirus
40/41 (19·0, 16·8–23·0), enterotoxigenic E coli (18·8,
Results
Of 2145 enrolled children, 1715 had complete follow-up to 16·5–23·8), norovirus (15·4, 13·5–20·1), astrovirus (15·0,
24 months, from whom 44 570 stools were collected. Of 12·0–19·5), Campylobacter jejuni or C coli (12·1, 8·5–17·2),
the 44 570 stools collected, 42 630 (95·6%) had sufficient Cryptosporidium (5·8, 4·3–8·3), and typical enter-
specimen available and 40 406 (90·7%) had valid quanti opathogenic E coli (5·4, 2·8–9·3). Although there were
tative PCR results for all pathogens included in the differences in the pathogen hierarchy by site (figure 2 and
aetiology analysis (table 1; appendix). After excluding appendix), the top five aetiologies at each site came
non-diarrhoeal stools collected within 7 days of a from these ten pathogens with the exception of
diarrhoeal episode, and pathogens with no association enteroaggregative E coli, which had the third highest
with diarrhoea in univariate analysis, 6625 diarrhoeal incidence in Fortaleza, Brazil (4·0 episodes per
and 30 968 non-diarrhoeal stools and 27 pathogens 100 child-years, 95% CI 0·2–9·8) and fifth highest in
were examined for aetiology (appendix). The modelled Haydom, Tanzania (9·7, 0·7–28·9). A more stringent
associations between pathogen quantity and diarrhoea definition of non-diarrhoeal stools which excluded those
were robust for age and diarrhoea severity (appendix). collected within 28 days of diarrhoea increased
420 children without complete follow-up were excluded attributable incidence by more than one episode per
from quantitative PCR testing; using the original 100 child-years for norovirus (2·4 episodes per
microbiological work-up, the prevalence of pathogens in 100 child-years), C jejuni or C coli (2·4), sapovirus (2·0),
diarrhoea was similar between children who were and Cryptosporidium (1·9), and enterotoxigenic E coli (1·2;
were not included in the quanti
tative PCR testing appendix). At the time of the study, rotavirus vaccine had
been introduced to the national programmes of Brazil,
(appendix).
In the first year of life, the incidence of diarrhoea Peru, and South Africa. Rotavirus was responsible for
was 304·9 episodes per 100 child-years, and rotavirus 8·9% of all attributable incidence among countries in
(23·9 episodes per 100 child-years, 95% CI 20·7–27·6), which rotavirus vaccine had not been introduced (the
adenovirus 40/41 (20·9, 17·4–25·8), sapovirus (18·1, second highest pathogen-specific burden) and only
13·4–23·3), norovirus (16·4, 13·7–22·6) and enter- 4·2% among countries where rotavirus vaccine had
otoxigenic E coli (14·9, 12·0–20·2) had the highest attribu been introduced (the eighth highest pathogen-specific
table incidences. In the second year of life, diarrhoea burden). Shigella had the highest attributable burden of
incidence was 242·7 episodes per 100 child-years, moderate-to-severe diarrhoea using the definition created
and Shigella (41·3, 95% CI 37·8–46·5), sapovirus for the Global Enteric Multicenter Study,6 whereas
(27·8, 23·4–33·4), enterotoxigenic E coli (22·8, rotavirus had the highest burden of severe diarrhoea
19·1–29·3), rotavirus (17·7, 15·5–20·6) and adenovirus using a modified Vesikari score (appendix).14
The funder of the study had no role in study design, data
collection, data analysis, data interpretation, or writing of
the report. The corresponding author had full access to
all the data in the study and had final responsibility for
the decision to submit for publication.
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0–11 months
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B

12–24 months

Shigella
Sapovirus
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Figure 1: Attributable
incidence of
pathogen-specific diarrhoea
at ages 0–11 months (A) and
12–24 months (B) in the
MAL-ED cohort study by
quantitative PCR
Error bars show 95% CI.
ETEC=enterotoxigenic E coli.
tEPEC=typical
enteropathogenic E coli.
EAEC=enteroaggregative
E coli. aEPEC=atypical
enteropathogenic E coli.
STEC=Shiga toxin-producing
E coli.
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78·7–91·1] vs 50·5%, [47·2–56·2]). Overall, viral diarrhoea
(36·4%, 95% CI 33·6–39·5) was more common than
bacterial (25·0%, 23·4–28·4) and parasitic diarrhoea
(3·5%, 3·0–5·2). In the second year of life, the proportion
of attribution to bacterial diarrhoea (43·3% in the second
year vs 31·9% in the first year) and parasitic diarrhoea
(6·8% vs 3·9%) increased, whereas the proportion of
attribution to viral diarrhoea decreased (49·9% vs 64·2%).
Next, we assessed the association between pathogen
attribution and distinguishing clinical characteristics
(table 2). Shigella diarrhoea was associated with blood in

Overall, 64·9% (95% CI 62·6–71·2) of diarrhoea
episodes could be attributed to an infectious aetiology by
quantitative PCR versus 32·8% (30·8–38·7) with the
original microbiology (appendix). Among the top ten
aetiologies, pathogen-attributable diarrhoeal burden was
markedly increased for adenovirus 40/41 and Shigella, and
to a lesser degree for astrovirus, enterotoxigenic E coli,
and typical EPEC. Sapovirus was not tested for in the
original MAL-ED study.13 The proportion of diarrhoea that
was attributable to pathogens was higher in the second
year of life than the first year of life (82·8% [95% CI

Shigella
Sapovirus
Rotavirus
Adenovirus 40/41
ETEC
Norovirus
Astrovirus
Campylobacter jejuni or C coli
Cryptosporidium
tEPEC

100

Attributable incidence per 100 child-years
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Peru*

Pakistan

South Africa*
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Country

Figure 2: Attributable incidence of pathogen-specific diarrhoea by site in the MAL-ED cohort study by quantitative PCR
The ten pathogens with the highest overall attributable incidence are shown. Error bars show 95% CI. ETEC=enterotoxigenic E coli. tEPEC=typical enteropathogenic
E coli. *Sites where rotavirus vaccine has been added to the national immunisation schedule.

Blood in stool
(n=315)

Fever
(n=2170)

Prolonged duration* Dehydration
(n=1381)
(n=692)

Vomiting
(n=1778)

High frequency†
(n=1697)

Severe‡ §
(n=1120)

4·53 (2·71–7·57)

1·30 (0·98–1·72)

1·19 (0·82–1·73)

0·59 (0·33–1·09)

0·68 (0·48–0·97)

1·08 (0·76–1·54)

0·69 (0·42–1·11)

Bacteria
Campylobacter jejuni
or C coli
tEPEC

0·24 (0·07–0·87)

1·19 (0·84–1·70)

1·09 (0·69–1·70)

0·94 (0·48–1·84)

0·99 (0·64–1·52)

0·82 (0·53–1·27)

1·36 (0·84–2·19)

ETEC

0·54 (0·29–1·02)

0·98 (0·77–1·25)

0·96 (0·69–1·34)

1·23 (0·78–1·93)

1·11 (0·87–1·41)

1·21 (0·94–1·57)

1·37 (0·98–1·92)

Shigella

7·39 (5·20–10·49)

1·32 (1·10–1·58)

1·66 (1·31–2·10)

1·55 (1·11–2·16)

0·81 (0·65–1·02)

1·73 (1·40–2·14)

1·28 (0·96–1·70)

Viruses
Adenovirus 40/41

1·06 (0·55–2·06)

1·22 (0·92–1·62)

0·87 (0·58–1·29)

2·14 (1·24–3·69)

1·29 (0·99–1·68)

0·95 (0·70–1·29)

1·36 (0·91–2·01)

Astrovirus

0·24 (0·09–0·62)

0·92 (0·71–1·20)

0·78 (0·55–1·11)

1·38 (0·90–2·12)

1·10 (0·83–1·46)

1·23 (0·92–1·65)

1·09 (0·75–1·58)

Norovirus

0·45 (0·20–0·99)

0·79 (0·58–1·07)

0·66 (0·44–1·00)

1·59 (0·95–2·67)

1·81 (1·36–2·42)

0·86 (0·61–1·23)

1·38 (0·91–2·09)

Rotavirus

0·46 (0·24–0·89)

1·47 (1·24–1·74)

0·79 (0·60–1·04)

3·23 (2·44–4·28)

2·31 (1·97–2·72)

1·66 (1·38–1·99)

2·46 (1·99–3·06)

Sapovirus

0·39 (0·21–0·74)

0·84 (0·68–1·05)

0·83 (0·62–1·11)

1·21 (0·84–1·74)

1·51 (1·22–1·88)

1·01 (0·79–1·29)

1·12 (0·83–1·53)

Protozoa
Cryptosporidium
No aetiology identified

0·25 (0·06–1·00)

1·26 (0·87–1·84)

1·50 (0·93–2·43)

1·57 (0·83–2·95)

1·27 (0·82–1·96)

1·06 (0·64–1·75)

1·29 (0·71–2·33)

0·69 (0·50–0·96)

0·84 (0·75–0·96)

1·03 (0·88–1·21)

0·48 (0·38–0·60)

0·61 (0·53–0·70)

0·72 (0·62–0·83)

0·59 (0·49–0·70)

Data are prevalence ratio (95% CI). tEPEC=typical enteropathogenic E coli. ETEC=enterotoxigenic E coli. *Diarrhoea for 7 days or longer. †More than six loose stools in 24 h. ‡Severity score of 6 or higher. §Score derived
from components of the Vesikari score.14 Analysis includes all episodes of diarrhoea with complete valid quantitative PCR results and clinical characteristics for the ten pathogens listed (n=6676).

Table 2: Clinical features associated with aetiology-specific diarrhoea
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stool, fever, prolonged duration, dehydration, and high
frequency, whereas rotavirus diarrhoea was associated
with fever, vomiting, dehydration, high frequency, and
high severity. All viral causes, with the exception of
astrovirus, were associated with vomiting. Non-infectious
diarrhoea was associated with the absence of each clinical
characteristic with the exception of prolonged duration.
Notably, 86·2% of the attributable incidence for Shigella
was non-dysenteric (appendix).
Using detection at any quantity, diarrhoeal stools had
a mean of 3·4 pathogens (SD 2·0) compared with
2·5 pathogens (1·8) in non-diarrhoeal stools (p<0·001).
Using a stringent quantitative cutoff to identify episodelevel aetiology (appendix), 2243 (33·9%) of 6625 episodes
had one pathogen, and 644 (9·7%) of 6625 episodes
had two or more pathogens (figure 3A). Frequently, no
infectious aetiology was identified for diarrhoeal episodes
that occurred in the first 6 months of life (appendix).
Among episodes with multiple aetiologies, rotavirus
and Shigella were usually the primary aetiologies, where
as typical enteropathogenic E coli, adenovirus 40/41,
and C jejuni or C coli were often secondary aetiologies
(figure 3B). The clinical phenotype of diarrhoea was
altered by co-pathogens. Among 1915 episodes with a
viral aetiology, co-attribution to Shigella was associated
with presence of blood (prevalence ratio 12·74, 95% CI
5·94–27·31) and prolonged duration (2·33, 1·44–3·78).
sodes with a bacterial aetiology,
Among 1264 epi
co-attribution to viral pathogens was associated with the
absence of blood (prevalence ratio 0·57, 95% CI
0·34–0·96) and vomiting (1·55, 1·11–2·16).
Because of the high Shigella burden, the suspected
benefit of treating Shigella independent of the presence
of blood, and because only a small minority of Shigella
diarrhoea episodes were dysenteric, we evaluated
whether other clinical characteristics could help inform
treatment decisions (table 3). We found that a prediction
score could identify most cases of Shigella diarrhoea
(sensitivity 50·4% [95% CI 46·7–54·1], specificity
84·0% [83·0–84·9], area under the curve [AUC] 0·783;
table 3) and the prediction scores were consistent across
sites with a high burden of disease (appendix). Age
was an important determinant; diarrhoeal stools in
children aged 6 months or younger were never positive,
diarrhoeal stools in children aged between 7–12 months
were positive only in the case of bloody diarrhoea, and
in the second year of life a broader combination of
clinical characteristics was sufficient. Complete score
components are shown in the appendix. This Shigella
score performed better than the presence of blood alone,
which is used in current guidelines as an indication for
treatment of shigellosis (sensitivity 14·5% [95% CI
12·1–17·3], specificity 96·5% [96·0–97·0], AUC 0·555;
table 3). Among Shigella diarrhoea episodes, longer
duration was associated with maternal report of blood
(odds ratio 1·10 per additional day of diarrhoea, 95% CI
1·02–1·18), suggesting bloody diarrhoea was a late

Figure 3: Aetiologic detections and co-infections in diarrhoea episodes
(A) Number of pathogens detected in diarrhoea episodes. Aetiologic quantity was defined as an AFe of 0·5 or
more. (B) Distribution of pathogen detections, stratified by aetiologic attribution. When more than one aetiologic
detection was present, the primary aetiology was defined as the pathogen with the highest AFe. Pathogens are
ordered according to the proportion of aetiologic detections for which they were the primary aetiology.
Cq=quantification cycles. ETEC=enterotoxigenic E coli. tEPEC=typical enteropathogenic E coli. AFe=attributable
fraction for that episode.
Disease
Presence of blood Shigella diarrhoea
(WHO guideline7)

Positive episodes, Sensitivity,
% (SD)
% (95% CI)
315 (4·7)

Specificity,
% (95% CI)

AUC

14·5 (12·1–17·3)

96·5 (96·0–97·0)

0·555
0·783

Shigella score

Shigella diarrhoea 1322 (19·8)

50·4 (46·7–54·1)

84·0 (83·0–84·9)

Viral score

Viral diarrhoea

1462 (21·9)

33·9 (31·8–36·1)

82·9 (81·8–84·0)

0·659

Cryptosporidium
score

Cryptosporidium
diarrhoea

957 (14·3)

36·1 (27·5–45·4)

86·1 (85·2–86·9)

0·701

Analysis included all episodes of diarrhoea with complete valid quantitative PCR results and clinical characteristics for
the top ten pathogens (n=6676). AUC=area under the curve of the receiver operating characteristic curve.

Table 3: Model-based prediction of diarrhoea aetiology

manifestation of disease. The performance of the Shigella
score was slightly improved in the subset of moderate-tosevere diarrhoea (AUC 0·824; appendix). Clinical
prediction scores performed less well for other pathogens
(table 3; appendix).
Overall, 3142 (47·1%) of 6676 diarrhoeal episodes in the
MAL-ED observational cohort study were treated with
an antibiotic. Defining appropriate antibiotic treatment
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Shigella diarrhoea (n=736)

Appropriate
antibiotics

Non-Shigella diarrhoea (n=5940)

Inappropriate
antibiotics

Inappropriately
not treated

Inappropriate
antibiotics

Not treated

Ratio of appropriate to either
inappropriate treatment or
non-treatment*

Observed in this study

260 (35·3%)

190 (25·8%)

286 (38·9%)

2692 (45·3%)

3248 (54·7%)

260:3168 (1:12·2)

Presence of blood
(WHO guideline)

107 (14·5%)

NA

629 (85·5%)

208 (3·5%)

5732 (96·5%)

107:837 (1:7·8)

Shigella clinical score

371 (50·4%)

NA

365 (49·6%)

951 (16·0%)

4989 (84·0%)

371:1316 (1:3·5)

Data are n (%), unless otherwise specified. Analysis includes all episodes of diarrhoea with complete valid quantitative PCR results and clinical characteristics for the top
ten pathogens (n=6676). NA=not applicable. *Numbers in parentheses represent the ratio of appropriate to either inappropriate treatment or non-treatment per
appropriate treatment.
Table 4: Potential impact of adherence to current guidelines or the model-based prediction score on appropriate antibiotic use for diarrhoea

post hoc, as treatment of Shigella diarrhoea with either
a macrolide or a fluoroquinolone, only 260 (8·3%) of
all 3142 antibiotic courses for diarrhoea were appro
priate (table 4). Of 736 Shigella diarrhoea episodes,
260 (35·3%) were treated appropriately, 190 (25·8%) were
treated inappropriately, and 286 (38·9%) were not
treated. Taken together, this translates to one appro
priately treated episode of Shigella diarrhoea for every
12·2 diarrhoea episodes that were treated inappropriately.
Adherence to existing WHO guidelines would greatly
restrict antibiotic use, in that only 315 (4·7%) of
6676 bloody diarrhoea episodes would be treated. How
ever, only 107 (14·5%) of 736 Shigella episodes would be
treated, with one appropriately treated episode for every
7·8 episodes treated inappropriately. Application of the
Shigella score would treat about half of all Shigella
episodes, while improving the efficiency of antibiotic
use, with one appropriate episode treated for every
3·5 episodes treated inappropriately.

Discussion
In this study, the application of quantitative molecular
diagnostics substantially altered previous estimates of
diarrhoea aetiology obtained from the prospective,
multisite MAL-ED cohort study. Of the five pathogens
with highest overall attributable incidence of diarrhoea,
only rotavirus and enterotoxigenic E coli, were in the
top five using the original microbiological work-up.14
Although underattribution to Shigella by traditional
bacteriology has been previously documented,6 under
attribution was substantially higher in this study:
quantitative PCR showed that the Shigella burden was
more than five times higher than the burden estimated by
culture. In the second year of life, more than one of every
five attributable episodes was Shigella diarrhoea. Although
evidence6 also suggests that the burden of adenovirus
40/41 has been substantially underestimated, sapovirus
had the second highest overall attributable incidence of
diarrhoea in these diverse community settings, which is
notable. A high prevalence of sapovirus diarrhoea has
been reported previously,25 but not across such diverse
geographical locations. The burden of astrovirus
8

diarrhoea was also higher than previously estimated.
Among the ten pathogens that were responsible for the
majority of cases of infectious diarrhoea, considerable
heterogeneity was observed in the pathogen hierarchy by
site. In comparison to the Global Enteric Multicenter
Study,6 in which a similar quantitative PCR analysis was
done, this cohort study captured the full denominator of
diarrhoea severity in the community setting. However,
four of the top five aetiologies (Shigella, rotavirus,
adenovirus 40/41, and enterotoxigenic E coli) were shared.
The modelled associations between pathogen quantity
and diarrhoea were largely consistent between the two
studies (appendix).
In this re-analysis of the MAL-ED community-based
cohort study with active surveillance for diarrhoea,
nearly two-thirds of diarrhoea could be attributed to a
pathogen by quantitative PCR, with a large increase in
attribution in the second year of life. We have previously
shown that quantitative PCR further narrowed this
aetiologic gap for severe diarrhoea,6 suggesting that a
sizeable proportion of diarrhoea collected in this study
in the first year of life might be non-infectious. Although
we used a standardised diarrhoea definition of three or
more loose stools in a 24 h period, this definition can
lack specificity in young children and those who are
exclusively breastfed.26
Diarrhoea is a syndrome with many causes, and the
clinical determination of aetiology on the basis of the
diarrhoea episode is difficult. We identified some
phenotypes of aetiology-specific diarrhoea, with rotavirus
and Shigella most strongly associated with specific
characteristics. In comparison, enterotoxigenic E coli
episodes were poorly differentiated, thus a tailored
clinical case definition for interventional studies might be
difficult.27 Despite using a stringent metric to identify
aetiology for individual episodes, we found multiple
aetiologies in one of every five episodes in which an
infectious aetiology was found. The presence of
copathogens predictably altered the clinical phenotype,
suggesting that interventional studies that do not account
for co-pathogens in pathogen-specific case definitions
might bias efficacy estimates towards the null.
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In this study, we found that blood in stool is a poor
marker for shigellosis, which is consistent with the
conclusions of previous studies.6,9,10 Shigella has been
associated with mortality in similar resource-limited
settings, an association that extends beyond dysentery,10
and in the companion Article by Rogawski and colleagues28
Shigella infection was strongly associated with linear
growth deficits. Thus, it is possible that current indications
for antibiotic treatment of diarrhoea are too restrictive.7,10 A
previous clinical trial29 found that watery Shigella responds
to treatment, and a randomised controlled trial
(NCT03130114) of antibiotic therapy for non-dysenteric
diarrhoea in high-risk children is ongoing. If treatment of
non-dysenteric Shigella is found to be beneficial, in the
absence of point-of-care testing, an improved syndromic
approach could be of benefit. In this study, in addition to
blood in stool, incorporation of other clinical characteristics
stratified by age improved identification of shigellosis.
We have previously reported antibiotic use at these
eight sites (4·9 courses per child-year),8 but a substantial
proportion of cases did not seem to be clinically
indicated. Almost half of all diarrhoea episodes in this
study were treated with antibiotics, and based on a
quantitative PCR gold standard, 91·7% of these
antibiotic courses were inappropriate. Since almost
1 billion episodes of diarrhoea occur annually in
children aged 5 years or younger,1 this translates to a
substantial amount of inappropriate antibiotic exposure,
which is high even in comparison to the amount
of inappropriate antibiotic prescribed in developed
countries for respiratory infections.30 Better adherence to
guidelines is clearly needed,8 however the guidelines
could also be revisited in view of improved data on
diarrhoeal aetiology. We provide proof of concept that the
use of readily-available criteria could reduce under
treatment of shigellosis with a modest trade-off of
increased inappropriate antibiotic treatment. However,
an accurate point-of-care diagnostic could offer substantial
additional benefit. Optimisation of antimicrobial use is a
strategic objective of the WHO Global Action Plan on
antimicrobial resistance, and we agree with calls31 that
guidelines should consider inappropriate antibiotic use
during their development process.
This study has several limitations. First, the MAL-ED
cohort study was designed to investigate long-term
sequelae of early enteric infections, and thus was not
powered for diarrhoea aetiology at the level of the site,
and diarrhoeal severity was lower than studies done in
the health-care setting. Application of these diagnostics
in broader surveillance networks can help extend these
estimates.1,5 We identified a score for shigellosis to show
that the syndromic treatment of diarrhoea could be
improved, however any score for clinical use would need
prospective derivation and validation, ideally in a study
that can also assess the efficacy of such an approach. Our
score is derived using the complete clinical phenotype of
each diarrhoea episode, whereas less information will be

available at the point of care, and early case detection and
management in the setting of active surveillance might
have changed the natural history of diarrhoea in patients
that would otherwise have presented for care. Our
definition of appropriate antibiotic use assumes a benefit
for treatment of non-dysenteric Shigella and no benefit
for treatment of other bacterial causes, and trials of
expanded antibiotic treatment for diarrhoea are urgently
needed to test this assumption. Without such data,
modification of the current clinical algorithm is
premature. Futhermore, our definition of appropriate
antibiotic use takes into account local susceptibility
information, but the evolution of antimicrobial resistance
could alter this.
In summary, using quantitative molecular diagnostics
we were able to identify ten pathogens responsible for
the majority of community-based childhood infectious
diarrhoea in diverse low-resource settings, including
several pathogens for which burdens have been
previously substantially underestimated. Although most
cases of infectious diarrhoea were of viral aetiology,
Shigella had the single highest attributable incidence.
However, less than one in five episodes of shigellosis
were accompanied by blood in stool. If non-dysenteric
Shigella requires antibiotic therapy, it might be possible
to leverage clinical characteristics to improve guidelines
for the syndromic management of childhood diarrhoea
in these settings.
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